Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Alzheimer's disease drug development pipeline: 2025
Alzheimer's disease drug development pipeline: 2025
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Jeffrey L. Cummings
,
Yadi Zhou
,
Garam Lee
,
Kate Zhong
,
Jorge Fonseca
,
Amanda M. Leisgang‐Osse
,
Feixiong Cheng
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70098
Similar Items
Alzheimer's disease drug development pipeline: 2026
by: Jeffrey L. Cummings, et al.
Published: (2026)
Biomarkers in Alzheimer's disease clinical trials: 2025
by: Amanda M. Leisgang Osse, et al.
Published: (2026)
Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation
by: Reina Tonegawa‐Kuji, et al.
Published: (2025)
Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
by: Jeffrey Cummings
Published: (2025)
Assessing safety and efficacy in subpopulations in Alzheimer's disease clinical trials: contextualizing representativeness
by: Guogen Shan, et al.
Published: (2025)